LLY Partners BioArctic
Eli Lilly partners with BioArctic to combine BrainTransporter technology with Lilly's undisclosed drug candidate for neurodegeneration treatment
BioArctic Partners With Eli Lilly Over Potential New Treatment To Combine BrainTransporter Technology with Lilly's Undisclosed Drug Candidate In Neurodegeneration; BioArctic Eligible To Receive $30M Upfront Payment